Canaan gets Nasdaq warning on minimum bid price
Rhea-AI Filing Summary
Canaan Inc. reported that it received a notice from Nasdaq on January 14, 2026 stating that its American depositary shares have closed below US$1.00 per share for 30 consecutive business days, putting the company out of compliance with Nasdaq’s minimum bid price rule. The notice does not immediately affect the listing or trading of the shares.
Canaan has 180 calendar days, until July 13, 2026, for its ADS closing bid price to meet or exceed US$1.00 per share for at least 10 consecutive business days to regain compliance. If it fails to do so, the company may seek an additional compliance period by applying to transfer its listing and, if necessary, committing to a reverse stock split, subject to Nasdaq staff’s determination. Until then, the ADSs will continue to trade on the Nasdaq Global Market while the company monitors its share price and considers reasonable measures to restore compliance.
Positive
- None.
Negative
- Nasdaq minimum bid deficiency and delisting risk: Canaan’s ADSs fell below the US$1.00 minimum bid for 30 consecutive business days, starting a compliance period that could lead to delisting if the price is not restored.
Insights
Nasdaq bid-price deficiency introduces potential future delisting risk for Canaan.
Canaan Inc. has been notified by Nasdaq that its ADSs failed to maintain the required US$1.00 minimum bid price for 30 consecutive business days, triggering a deficiency under Listing Rule 5550(a)(2). The company retains its current Nasdaq Global Market listing for now, and the notice alone does not change trading status.
Nasdaq has granted Canaan a 180-day compliance window, until July 13, 2026, during which the ADS closing bid must be at or above US$1.00 for at least 10 consecutive business days. If compliance is not regained, Canaan may pursue an additional period by filing a transfer application, paying a US$5,000 fee, and demonstrating that it meets other listing standards while indicating plans, including a potential reverse stock split, to cure the bid-price deficiency.
The filing notes that Nasdaq staff will review whether the company can realistically cure the deficiency; otherwise, its securities could become subject to delisting. Future company actions, such as any approved reverse split or listing transfer, would be disclosed in subsequent communications once decided.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did Canaan Inc. (CAN) receive a Nasdaq minimum bid price notice?
How long does Canaan Inc. (CAN) have to regain Nasdaq minimum bid compliance?
What happens if Canaan Inc. does not regain compliance by July 13, 2026?
Are Canaan Inc. (CAN) ADSs still trading on the Nasdaq Global Market after the notice?
What actions might Canaan Inc. take to address the Nasdaq bid price deficiency?
Under which Nasdaq rules is Canaan Inc.’s disclosure being made?
AI-generated analysis. How Rhea-AI works. Not financial advice.
